Log In
Print this Print this

Hereditary Colorectal Cancer DNA Insight

  Manage Alerts
Collapse Summary General Information
Company Pathway Genomics Corp.
DescriptionDiagnostic test using next-generation sequencing (NGS) technology to identify gene alterations that increase a patient's risk of developing certain cancer types
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsScan a patient's genome for conditions related to colorectal cancer including Lynch syndrome, familial adenomatous, polyposis, Li-Fraumeni syndrome and juvenile polyposis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today